These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

467 related items for PubMed ID: 18224243

  • 1. The polyol pathway as a mechanism for diabetic retinopathy: attractive, elusive, and resilient.
    Lorenzi M.
    Exp Diabetes Res; 2007; 2007():61038. PubMed ID: 18224243
    [Abstract] [Full Text] [Related]

  • 2. Studies of rat and human retinas predict a role for the polyol pathway in human diabetic retinopathy.
    Dagher Z, Park YS, Asnaghi V, Hoehn T, Gerhardinger C, Lorenzi M.
    Diabetes; 2004 Sep; 53(9):2404-11. PubMed ID: 15331552
    [Abstract] [Full Text] [Related]

  • 3. Aldose reductase / polyol inhibitors for diabetic retinopathy.
    Obrosova IG, Kador PF.
    Curr Pharm Biotechnol; 2011 Mar 01; 12(3):373-85. PubMed ID: 20939801
    [Abstract] [Full Text] [Related]

  • 4. A selective aldose reductase inhibitor of a new structural class prevents or reverses early retinal abnormalities in experimental diabetic retinopathy.
    Sun W, Oates PJ, Coutcher JB, Gerhardinger C, Lorenzi M.
    Diabetes; 2006 Oct 01; 55(10):2757-62. PubMed ID: 17003340
    [Abstract] [Full Text] [Related]

  • 5. Polymorphisms of sorbitol dehydrogenase (SDH) gene and susceptibility to diabetic retinopathy.
    Amano S, Yamagishi S, Koda Y, Tsuneoka M, Soejima M, Okamoto T, Inagaki Y, Yamada K, Kimura H.
    Med Hypotheses; 2003 Apr 01; 60(4):550-1. PubMed ID: 12615520
    [Abstract] [Full Text] [Related]

  • 6. The Role of Aldose Reductase in Polyol Pathway: An Emerging Pharmacological Target in Diabetic Complications and Associated Morbidities.
    Gupta JK.
    Curr Pharm Biotechnol; 2024 Apr 01; 25(9):1073-1081. PubMed ID: 37649296
    [Abstract] [Full Text] [Related]

  • 7. Reduction of Glut1 in the Neural Retina But Not the RPE Alleviates Polyol Accumulation and Normalizes Early Characteristics of Diabetic Retinopathy.
    Holoman NC, Aiello JJ, Trobenter TD, Tarchick MJ, Kozlowski MR, Makowski ER, De Vivo DC, Singh C, Sears JE, Samuels IS.
    J Neurosci; 2021 Apr 07; 41(14):3275-3299. PubMed ID: 33622781
    [Abstract] [Full Text] [Related]

  • 8. Regulation of intracellular glucose and polyol pathway by thiamine and benfotiamine in vascular cells cultured in high glucose.
    Berrone E, Beltramo E, Solimine C, Ape AU, Porta M.
    J Biol Chem; 2006 Apr 07; 281(14):9307-13. PubMed ID: 16452468
    [Abstract] [Full Text] [Related]

  • 9. Association study of sorbitol dehydrogenase -888G>C polymorphism with type 2 diabetic retinopathy in Caucasian-Brazilians.
    Ferreira FN, Crispim D, Canani LH, Gross JL, dos Santos KG.
    Exp Eye Res; 2013 Oct 07; 115():140-3. PubMed ID: 23850972
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats.
    Cameron NE, Cotter MA, Basso M, Hohman TC.
    Diabetologia; 1997 Mar 07; 40(3):271-81. PubMed ID: 9084964
    [Abstract] [Full Text] [Related]

  • 11. Aldose reductase inhibitor fidarestat attenuates leukocyte-endothelial interactions in experimental diabetic rat retina in vivo.
    Hattori T, Matsubara A, Taniguchi K, Ogura Y.
    Curr Eye Res; 2010 Feb 07; 35(2):146-54. PubMed ID: 20136425
    [Abstract] [Full Text] [Related]

  • 12. Elevated glucose levels increase retinal glycolysis and sorbitol pathway metabolism. Implications for diabetic retinopathy.
    Van den Enden MK, Nyengaard JR, Ostrow E, Burgan JH, Williamson JR.
    Invest Ophthalmol Vis Sci; 1995 Jul 07; 36(8):1675-85. PubMed ID: 7601647
    [Abstract] [Full Text] [Related]

  • 13. Aldose Reductase and the Polyol Pathway in Schwann Cells: Old and New Problems.
    Niimi N, Yako H, Takaku S, Chung SK, Sango K.
    Int J Mol Sci; 2021 Jan 21; 22(3):. PubMed ID: 33494154
    [Abstract] [Full Text] [Related]

  • 14. In vitro retinal and erythrocyte polyol pathway regulation by hormones and an aldose reductase inhibitor.
    Hotta N, Kakuta H, Koh N, Fukasawa H, Yasuma T, Awaya S, Sakamoto N.
    Diabetes Res Clin Pract; 1991 Oct 21; 14(1):29-35. PubMed ID: 1748061
    [Abstract] [Full Text] [Related]

  • 15. Recent studies of aldose reductase enzyme inhibition for diabetic complications.
    Suzen S, Buyukbingol E.
    Curr Med Chem; 2003 Aug 21; 10(15):1329-52. PubMed ID: 12871133
    [Abstract] [Full Text] [Related]

  • 16. Dietary sources of aldose reductase inhibitors: prospects for alleviating diabetic complications.
    Saraswat M, Muthenna P, Suryanarayana P, Petrash JM, Reddy GB.
    Asia Pac J Clin Nutr; 2008 Aug 21; 17(4):558-65. PubMed ID: 19114390
    [Abstract] [Full Text] [Related]

  • 17. Sorbitol dehydrogenase overexpression potentiates glucose toxicity to cultured retinal pericytes.
    Amano S, Yamagishi Si, Kato N, Inagaki Y, Okamoto T, Makino M, Taniko K, Hirooka H, Jomori T, Takeuchi M.
    Biochem Biophys Res Commun; 2002 Nov 29; 299(2):183-8. PubMed ID: 12437967
    [Abstract] [Full Text] [Related]

  • 18. The effects of an aldose reductase inhibitor upon the sorbitol pathway, fructose-1-phosphate and lactate in the retina and nerve of streptozotocin-diabetic rats.
    Poulsom R, Mirrlees DJ, Earl DC, Heath H.
    Exp Eye Res; 1983 May 29; 36(5):751-60. PubMed ID: 6406254
    [Abstract] [Full Text] [Related]

  • 19. Aldose reductase in retinal mural cells.
    Buzney SM, Frank RN, Varma SD, Tanishima T, Gabbay KH.
    Invest Ophthalmol Vis Sci; 1977 May 29; 16(5):392-6. PubMed ID: 404268
    [Abstract] [Full Text] [Related]

  • 20. Inhibitory effects of Ganoderma applanatum on rat lens aldose reductase and sorbitol accumulation in streptozotocin-induced diabetic rat tissues.
    Jung SH, Lee YS, Shim SH, Lee S, Shin KH, Kim JS, Kim YS, Kang SS.
    Phytother Res; 2005 Jun 29; 19(6):477-80. PubMed ID: 16114079
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.